{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:07:10Z","timestamp":1771013230641,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["174615"],"award-info":[{"award-number":["174615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Spinal muscular atrophy is a common neurodegenerative disorder that has recently been considered for inclusion in the next generation of newborn screening regimens. We sought to validate liquid microbead arrays for the identification of affected individuals by direct DNA analysis.<\/jats:p>\n               <jats:p>Methods: Assays were created to detect the homozygous deletions in exon 7 of the SMN1 gene found in approximately 95% of affected individuals by use of 2 different microbead chemistries on the Luminex 200: MultiCode-PLx and Tag-It. A series of 367 blood spots including 164 from affected individuals, 46 from known carriers, and 157 from unaffected individuals were then analyzed with each assay.<\/jats:p>\n               <jats:p>Results: The MultiCode-PLx assay required 4.2 h to perform and provided correct identification of all 164 samples from affected individuals. Correct exclusion was also made for all 46 carrier and 157 unaffected individual samples. The Tag-It assay required 6.8 h, detected all samples from affected individuals, and excluded all but 1 (99.5%) of the samples from carriers and unaffected individuals. Neither method was sensitive to increasing copy numbers of the SMN2 gene.<\/jats:p>\n               <jats:p>Conclusions: Both methods showed high sensitivity and specificity for the detection of patients with spinal muscular atrophy. For both methods, ample DNA was extracted from all blood spots for analysis, and SMN2 copy numbers did not interfere. Liquid bead arrays represent a robust method for DNA analysis in newborn screening laboratories.<\/jats:p>","DOI":"10.1373\/clinchem.2007.092312","type":"journal-article","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T21:09:14Z","timestamp":1190408954000},"page":"1879-1885","source":"Crossref","is-referenced-by-count":26,"title":["Assessment of Liquid Microbead Arrays for the Screening of Newborns for Spinal Muscular Atrophy"],"prefix":"10.1093","volume":"53","author":[{"given":"Robert E","family":"Pyatt","sequence":"first","affiliation":[{"name":"Department of Pathology, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C","family":"Mihal","sequence":"first","affiliation":[{"name":"Department of Pathology, Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W","family":"Prior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2020022802532448100_R1","doi-asserted-by":"crossref","unstructured":"Tarini BA, Christakis DA, Welch GW. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics2007;118:448-456.","DOI":"10.1542\/peds.2005-2026"},{"key":"2020022802532448100_R2","doi-asserted-by":"crossref","unstructured":". American College of Medical Genetics, American Society of Human Genetics, Test and Technology Transfer Committee Working Group. Tandem mass spectrometry in newborn screening. Genet Med2000;2:267-269.","DOI":"10.1097\/00125817-200007000-00011"},{"key":"2020022802532448100_R3","doi-asserted-by":"crossref","unstructured":"Howell RR. The high price of false positives. Mol Genet Metab2006;87:180-183.","DOI":"10.1016\/j.ymgme.2005.10.004"},{"key":"2020022802532448100_R4","doi-asserted-by":"crossref","unstructured":"Pearn J. Genetic studies of acute infantile spinal muscular atrophy (SMA type I): an analysis of sex ratios, segregation ratios, and sex influence. J Med Genet1978;15:414-417.","DOI":"10.1136\/jmg.15.6.414"},{"key":"2020022802532448100_R5","doi-asserted-by":"crossref","unstructured":"Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord1995;5:3-5.","DOI":"10.1016\/0960-8966(94)00075-K"},{"key":"2020022802532448100_R6","doi-asserted-by":"crossref","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A1999;96:6307-6311.","DOI":"10.1073\/pnas.96.11.6307"},{"key":"2020022802532448100_R7","doi-asserted-by":"crossref","unstructured":"Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis1996;3:97-110.","DOI":"10.1006\/nbdi.1996.0010"},{"key":"2020022802532448100_R8","doi-asserted-by":"crossref","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Violett L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell1995;80:155-165.","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"2020022802532448100_R9","doi-asserted-by":"crossref","unstructured":"Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA determining gene SMN. Hum Mol Genet2000;9:259-265.","DOI":"10.1093\/hmg\/9.2.259"},{"key":"2020022802532448100_R10","doi-asserted-by":"crossref","unstructured":"Cartegni L, Krainer AR. Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet2002;30:377-384.","DOI":"10.1038\/ng854"},{"key":"2020022802532448100_R11","doi-asserted-by":"crossref","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet1999;8:1177-1183.","DOI":"10.1093\/hmg\/8.7.1177"},{"key":"2020022802532448100_R12","doi-asserted-by":"crossref","unstructured":"Cartegni L, Hastings Ml, Calarco JA, de Stanchina E, Krainer AR. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet2006;78:63-77.","DOI":"10.1086\/498853"},{"key":"2020022802532448100_R13","doi-asserted-by":"crossref","unstructured":"Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med2002;4:20-26.","DOI":"10.1097\/00125817-200201000-00004"},{"key":"2020022802532448100_R14","doi-asserted-by":"crossref","unstructured":"Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol2005;57:704-712.","DOI":"10.1002\/ana.20473"},{"key":"2020022802532448100_R15","doi-asserted-by":"crossref","unstructured":"Carlson MD. Recent advances in newborn screening for neurometabolic disorders. Curr Opin Neurol2004;17:133-138.","DOI":"10.1097\/00019052-200404000-00008"},{"key":"2020022802532448100_R16","doi-asserted-by":"crossref","unstructured":"Wilcken B. Ethical issues in newborn screening and the impact of new technologies. Eur J Pediatr2003;162:S62-S66.","DOI":"10.1007\/s00431-003-1355-z"},{"key":"2020022802532448100_R17","doi-asserted-by":"crossref","unstructured":"Green NS, Pass KA. Neonatal screening by DNA microarray: spots and chips. Nat Rev Genet2005;6:147-151.","DOI":"10.1038\/nrg1526"},{"key":"2020022802532448100_R18","doi-asserted-by":"crossref","unstructured":"Saxena A. Issues in newborn screening. Genet Test2003;7:131-134.","DOI":"10.1089\/109065703322146812"},{"key":"2020022802532448100_R19","unstructured":"The Luminex Corporation. http:\/\/Luminexcorp.com (accessed April 2007).."},{"key":"2020022802532448100_R20","doi-asserted-by":"crossref","unstructured":"Pyatt RE, Prior TW. A feasibility study for the newborn screening of spinal muscular atrophy. Genet Med2006;8:428-437.","DOI":"10.1097\/01.gim.0000227970.60450.b2"},{"key":"2020022802532448100_R21","doi-asserted-by":"crossref","unstructured":"McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet1997;60:1411-1422.","DOI":"10.1086\/515465"},{"key":"2020022802532448100_R22","doi-asserted-by":"crossref","unstructured":"Bortolin S, Black M, Modi H, Boszko I, Kobler D, Fieldhouse D, et al. Analytical validation of the Tag-It high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clin Chem2004;50:2028-2036.","DOI":"10.1373\/clinchem.2004.035071"},{"key":"2020022802532448100_R23","doi-asserted-by":"crossref","unstructured":"Pietz BC, Warden MB, DuChateau BK, Ellis TM. Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol2005;66:1174-1182.","DOI":"10.1016\/j.humimm.2005.08.243"},{"key":"2020022802532448100_R24","doi-asserted-by":"crossref","unstructured":"Johnson SC, Marshall DJ, Harms G, Miller CM, Sherrill CB, Beaty EL, et al. Multiplexed genetic analysis using expanded genetic alphabet. Clin Chem2004;50:2019-2027.","DOI":"10.1373\/clinchem.2004.034330"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/53\/11\/1879\/32689805\/clinchem1879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/53\/11\/1879\/32689805\/clinchem1879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T02:57:03Z","timestamp":1582858623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/53\/11\/1879\/5627229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2007.092312","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,11,1]]},"published":{"date-parts":[[2007,11,1]]}}}